Identification of new genetic risk factors for prostate cancer.

نویسندگان

  • Michelle Guy
  • Zsofia Kote-Jarai
  • Graham G Giles
  • Ali Amin Al Olama
  • Sarah K Jugurnauth
  • Shani Mulholland
  • Daniel A Leongamornlert
  • Stephen M Edwards
  • Jonathan Morrison
  • Helen I Field
  • Melissa C Southey
  • Gianluca Severi
  • Jenny L Donovan
  • Freddie C Hamdy
  • David P Dearnaley
  • Kenneth R Muir
  • Charmaine Smith
  • Melisa Bagnato
  • Audrey T Ardern-Jones
  • Amanda L Hall
  • Lynne T O'Brien
  • Beatrice N Gehr-Swain
  • Rosemary A Wilkinson
  • Angela Cox
  • Sarah Lewis
  • Paul M Brown
  • Sameer G Jhavar
  • Malgorzata Tymrakiewicz
  • Artitaya Lophatananon
  • Sarah L Bryant
  • Alan Horwich
  • Robert A Huddart
  • Vincent S Khoo
  • Christopher C Parker
  • Christopher J Woodhouse
  • Alan Thompson
  • Tim Christmas
  • Chris Ogden
  • Cyril Fisher
  • Charles Jameson
  • Colin S Cooper
  • Dallas R English
  • John L Hopper
  • David E Neal
  • Douglas F Easton
  • Rosalind A Eeles
چکیده

There is evidence that a substantial part of genetic predisposition to prostate cancer (PCa) may be due to lower penetrance genes which are found by genome-wide association studies. We have recently conducted such a study and seven new regions of the genome linked to PCa risk have been identified. Three of these loci contain candidate susceptibility genes: MSMB, LMTK2 and KLK2/3. The MSMB and KLK2/3 genes may be useful for PCa screening, and the LMTK2 gene might provide a potential therapeutic target. Together with results from other groups, there are now 23 germline genetic variants which have been reported. These results have the potential to be developed into a genetic test. However, we consider that marketing of tests to the public is premature, as PCa risk can not be evaluated fully at this stage and the appropriate screening protocols need to be developed. Follow-up validation studies, as well as studies to explore the psychological implications of genetic profile testing, will be vital prior to roll out into healthcare.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ژنتیک مولکولی، تشخیص، پیشگیری و ژن درمانی در سرطان پروستات:  مقاله مروری

The prostate is a small gland located below the bladder and upper part of the urethra. In developed countries prostate cancer is the second common cancer (after skin cancer), and also the second leading cause of cancer death (after lung cancer) among men. The several studies have been shown prostate cancer familial aggregation. The main reason for this aggregation is inheritance included genes....

متن کامل

Secondary cancers during the radiotherapy of prostate cancer: a review article

Prostate cancer is the most common and second leading cause of death among men in the world. Nowadays, radiotherapy has been known as one of the most affecting methods for prostate cancer treatment. Nevertheless, radiotherapy is accompanied by the concern of developing secondary cancers by the scattered radiation to the neighbor  organs at risk. Several studies have shown that secondary cancers...

متن کامل

بررسی اپیدمیولوژیک نئوپلاسم های پروستات در شهر بیرجند

Background and Aim: Prostate gland is one of the most important exocrine gland in the male genital system, whose neoplasms are very common in Iran and other countries. The incidence of the disease is not the same among different racial communities. Therefore, epidemiologic studies can be useful in our country. This study was aimed to determine the epidemiologic characteristics of prostate neopl...

متن کامل

The IGSF1, Wnt5a, FGF14, and ITPR1 Gene Expression and Prognosis Hallmark of Prostate Cancer

Background: Prostate cancer is considered as the second leading cause of cancer related death in men worldwide and the third frequent cancer among Iranian men. Despite the use of PSA as the only biomarker for early diagnosis of prostate cancer, its application in clinical settings is under debate. Therefore, the introduction of new molecular markers for early detection of prostate cancer is nee...

متن کامل

Exploring the spatial patterns of three prevalent cancer latent risk factors in Iran; Using a shared component model

Background and aims: The aim of this study was the modeling of the incidence rates of Colorectal, breast and prostate cancers using a shared component model in order to explore the spatial pattern of their shared risk factors (i.e., obesity and low physical activity) affecting on cancer incidence, and also to estimate the relative weight of these shared components. Methods: In this study,...

متن کامل

Polymorphisms in Toll-like receptor genes--implications for prostate cancer development.

Toll-like receptors are key players in initiation of innate immune response of the host. In addition to innate immunity they can also induce adaptive immune responses. The concept that inflammation can promote chronic prostatic diseases, such as benign prostatic hyperplasia or prostate carcinoma is supported by several new findings. Epidemiological data have correlated prostatitis with an incre...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Asian journal of andrology

دوره 11 1  شماره 

صفحات  -

تاریخ انتشار 2009